11) The breast Flashcards

1
Q

Describe the structure of a normal breast

A

Glandular & supporting fibrous tissue embedded within fatty matrix, together with blood vessels, lymphatics & nerves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where is the location of mammary glands in the breast?

A

Subcutaneous tissue overlying pectoralis major & minor
Consist of 15-20 lobulated masses of tissues
Fibrous tissue connecting the lobes & adipose tissue between them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is each lobe of the breast made up of?

A

Lobules of alveoli, blood vessels & lactiferous ducts
Alveoli - site of milk synthesis
Myoepithelial cells, smooth muscle cells responsible for milk let down surround the alveoli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What determines the size of the non-lactating breast?

A

The amount of fat surrounding the glandular tissue
Roughly circular body of breast rests in a bed that extends from:
Lateral sternal edge to midaxillary line
2nd rib to 6th rib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List the constituents of human milk in the first week after birth

A

Up to 40ml/day of Colostrum secreted
Colostrum contains less water soluble vitamins, fat & sugar than later milk but much more protein, fat soluble vitamins & immunoglobulins
Over the following 2-3 weeks, IgG & total protein declines, fat & sugar rise to produce mature milk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What constitutes mature human milk?

A

Mature milk is produced for as long as the baby suckles (from week 2/3 breastfeeding)
Energy value of 27MJ/litre, pH 7.0
Composition: 90% water, 7% Lactose, 2% Fat
Proteins: Lactoglobulin (maternal IgG), Lactalbumin, Minerals, Vitamins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is milk produced in the lactating breast?

A

Synthesis of milk takes place in Alveolar cells
Fats: synthesised in SER, then membrane bound droplets towards lumen
Protein: Passes through Golgi, secreted by exocytosis
Sugar: Synthesised & secreted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What hormones control the growth & development of mammary tissues?

A

Birth, few lactiferous ducts are present, breast remains this way until puberty
Puberty, oestrogens cause ducts to sprout & branch, the ends form masses of cells, later become alveoli
With each menstrual cycle, changes in breast tissue with changes in oestrogen & progesterone levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What happens to mammary tissue during pregnancy?

A

High progesterone:oestrogen ratio favours development of alveoli, but not secretion
Hypertrophy of ductular-lobular-alveolar system
Prominent lobules form
Alveolar cells differentiate to be capable of milk production from mid gestation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What happens to milk production if an infant does not suckle?

A

Birth, progesterone falls sharply, less sharp fall of oestrogen
Breast becomes responsive to prolactin secreted from anterior pituitary
If infant doesn’t suckle, prolactin levels fall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does suckling help to maintain breast milk production?

A

Suckling initiates & maintains secretion by neuro-endocrine reflex by mechanically stimulating receptors in nipple
Impulses pass to brain stem & hypothalamus to reduce dopamine secretion & vaso-active intestinal peptide, promoting prolactin
Amount of milk produced before next feed depends on suckling stimulus
Milk continuously produced between feeds, accumulates in ducts, increases turgor of breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is milk ‘let down’ controlled by hormones?

A

Caused by dramatic increase in secretion of Oxytocin from posterior pituitary
Oxytocin causes myoepithelial cells surrounding alveoli to contract
Infants don’t suck from breast, must learn from bottle
As suckling causes release of oxytocin, suckling also important, keeps uterus clamped down on open placenta blood vessels
‘Let down’ reflex can be conditioned, often begins before baby reaches nipple

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is the cessation of lactation produced?

A

Lactation maintenance dependent on suckling, to promote prolactin & oxytocin to remove milk
Suckling stops, production of milk stops
Due to lower prolactin levels & turgor-induced damage to breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

A reduction in prolactin helps the cessation of lactation. What else does it do?

A

Prolactin secretion also reduces fertility

New pregnancy less likely until infant stops suckling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are common breast diseases?

A

Inflammatory conditions
Benign epithelial lesions
Stromal tumours
Breast carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the differences between physiological & pathological changes of the breast?

A

Physiological - Changes or symptoms that come about due to normal breast physiology
Pathological - Changes or symptoms that come about due to underlying breast pathology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Name some physiological breast changes

A

Prepubertal breast - few lobules
Menarche (first cycle/onset of puberty) - Increased number lobules, increased volume of interlobular stroma
Menstrual cycle - Follicular phase - lobules inactive, After ovulation - cell proliferation & stromal oedema, Menstruation - Decrease in size of lobules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What physiological breast changes take place during pregnancy?

A

Increase in size & number of follicles
Decrease in stroma
Secretory changes

Cessation of lactation - Atrophy of lobules but not to former levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What physiological breast changes take pace with increasing age?

A

Terminal duct lobular units (TDLUs) decrease in number & size
Interlobular stroma replaced by adipose tissue (mammograms easier to interpret)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Name some pathological breast changes that take place

A

Disorders of development - Milk line remnants (3rd nipples). accessory axillary breast tissue
Inflammatory conditions - Acute mastitis, duct ectasia, fat necrosis
Benign epithelial lesions - Fibrocystic change, epithelial hyperplasia, papilloma
Stromal tumours - Fibroadenoma, phyllodes tumours, lipoma, hamartoma
Gynaecomastia
Breast carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe the clinical presentation of breast pain

A

Cyclical & diffuse - often physiological
Non-cyclical & focal - ruptured cysts, injury, inflammation
Occasionally the presenting complaint in breast cancer

22
Q

Describe the clinical presentation of a palpable mass in the breast

A

May represent normal nodularity
Worrying if hard, craggy & fixed
Invasive carcinomas, fibroadenomas, cysts

23
Q

Describe the clinical presentation of nipple discharge

A

Most concerning if spontaneous or unilateral
Milky - endocrine disorders (e.g. pituitary adenoma), side effect of medication (e.g. OCP)
Bloody or serous - benign lesions (e.g. papilloma), duct ectasia, occasionally malignant

24
Q

What breast changes may occur and present clinically?

A
Pain
Palpable mass
Nipple discharge
Skin changes
Lumpiness
Mammographic abnormalities
25
Describe the clinical use of mammographies
Breast screening programme Easier to detect lesions in older women (more adipose) 50-70 year olds invited every 3 years Currently being extended 47-73 Densities - invasive carcinomas, fibroadenomas, cysts Calcifications - Ductal Carcinoma In Situ (DCIS), benign changes
26
Describe the incidence of fibroadenomas, phyllodes tumours & breast cancer
Fibroadenomas - Any age in reproductive period, often < 30yrs, most common benign tumour Phyllodes tumour - Most present in 6th decade Breast cancer - Rare before 25yrs except familial, incidence increases with age, 77% in women >50yrs, average age of diagnosis is 64yrs Most common non-skin malignancy in women
27
How are breast lesions (incl. breast cancer) investigated & diagnosed?
Triple approach: Clinical: Hx, FHx, examination Radiographic imaging: Mammogram & USS Pathology: Fine needle aspiration cytology (FNAC) & core biopsy
28
What is acute mastitis?
``` Usually Staphylococcus aureus infection from nipple cracks & fissures Almost always during lactation (benign) Erythematous painful breast, often fever May produce breast abscesses Treated by expressing milk & antibiotics ```
29
What is duct ectasia?
Dilation & inflammation of lactiferous duct Often patient's in 50's & 60's May have peri-areolar mass and/or nipple discharge Can mimic carcinoma clinically
30
What is fat necrosis?
Presents as a mass, skin changes or mammographic abnormality Often history of trauma or surgery Can mimic carcinoma clinically & mammographically
31
What is gynaecomastia?
Enlargement of the male breast Unilateral or bilateral Seen at puberty & in elderly Can indicate hormonal abnormality, cirrhosis of liver (oestrogen not metabolised effectively), functioning testicular tumour Can occur with drugs - alcohol, marijuana, heroin, anabolic steroids Can mimic male breast cancer, especially if unilateral
32
Describe the features of fibrocystic changes of the breast
Benign epithelial lesions, very common May present as mass/mammographic abnormality Mass often disappears after fine needle aspiration Histology - cyst formation, fibrosis, apocrine metaplasia Can mimic carcinoma clinically & mammographically
33
Describe the features of epithelial hyperplasia
Benign epithelial lesions Proliferation of epithelial cells which fill & distend ducts & lobules Associated with slight increased risk of carcinoma If atypical, higher increased risk of carcinoma
34
Describe the features of papilloma
Benign epithelial lesions Benign tumours, growing finger-like projections outwards Large duct papillomata usually in lactiferous ducts, near nipple Smaller duct papillomata deeper in breast May present with nipple discharge (+/-blood) or small palpable mass Histology - Intraduct lesion consisting of multiple branching fibrovascular cores covered by myoepithelia & epithelial cells
35
Describe the features of fibroadenoma
Stromal tumour, can be mulitple & bilateral Presents with mass, usually mobile/mammographic abnomality Can grow v large, replace most of breast Macroscopically - well defined boundaries, rubbery, greyish/white Histology - mixture, stromal & epithelial elements Can mimic carcinoma
36
Describe the features of a phyllodes tumour
Stromal tumour Mass/mammographic abnormality Benign (most), borderline & malignant types Can be v large, involve entire breast Histology - nodules of proliferating stroma covered by epithelium (phullon = leaf), stroma more cellular & atypical than fibroadenomas Need to be excised with wide margin or may recur Malignant - aggressive, recur local & metastasise via bloodstream
37
What are the risk factors for breast cancer?
Most related to oestrogen exposure Gender (^ females), Longer interval between menarche & menopause (longer exposure), Reproductive history (age at 1st pregnancy & no.), Breast feeding, Obesity & high fat diet, Exogenous risks (HRT), Geographic influence (USA/Europe high), atypical changes on previous biopsy, Radiation exposure, Genetics
38
What are the genetic risk factors for breast cancer?
3% all breast cancers & 25% familial cancers attributed to mutations in BRCA1 or BRCA2 tumour suppressor genes Lifetime risk for female carriers is 60-85% Median age at diagnosis ~20yrs earlier than sporadic cases Carriers may undergo prophylactic mastectomies p53 may also be involved
39
How are breast carcinomas classified?
~90% adenocarcinomas Divided into in situ & invasive Can be ductal or lobular
40
What are the features of an in situ carcinoma?
Neoplastic population of cells limited to ducts & lobules by basement membrane Myoepithelial cells preserved Does not invade into vessels, cannot metastasise Cells can extend to nipple skin without crossing basement membrane - Paget's disease - Unilateral red & crusting nipple
41
What are the features of a ductal carcinoma in situ (DCIS)?
Mammographic calcifications, clusters or linear & branching or presents with mass can spread through ducts & lobules & be very extensive Histologically - central (comedo) necrosis with calcification Can progress to invasive carcinoma
42
What are the features of an invasive carcinoma?
Carcinoma invaded beyond basement membrane into stroma Can invade vessels & metastasise to lymph nodes & other sites Usually presents as mass/mammographic abnormality By time cancer is palpable, >50% pts will have axillary lymph node metastases
43
What are the features of an invasive ductal carcinoma, no specific type (IDC-NST)?
70-80% of invasive carcinomas Well-differentiated type - tubules lined by atypical cells Poorly-differentiated type - sheets of pleomorphic cells
44
What are the features of an invasive lobular carcinoma?
Inifiltrating cells in a single file, cells lack cohesion
45
What other types of invasive carcinomas are there?
Tubular Mucinous Medullary Papillary
46
Where does breast cancer usually metastasise to?
Via lymphatics, usually in ipsilateral axilla Distant spread via blood vessels: Lungs, Liver, Bones, Brain
47
Invasive lobular carcinomas can spread to odd sites such as where?
``` Peritoneum Retroperitoneum Leptomeninges GI tract Ovaries Uterus ```
48
What factors determine breast cancer prognosis?
In situ disease or invasive carcinoma Histological subtype - IDC-NST has poorer prognosis Tumour grade Tumour stage - TMN
49
What local & regional approaches are there for treating breast cancer?
Breast surgery - Mastectomy or breast conserving surgery Axillary surgery - Extent depending on whether there are nodes involved Post-operative radiotherapy to chest & axilla
50
What systemic approaches are there for controlling/treating breast cancer?
Chemotherapy Hormonal treatment - Tamoxifen if a high amount of oestrogen receptors found on assessment Herceptin treatment - Depends on amount of Her2 receptors found on assessment